Research Overview · Research Use Only
Tesamorelin: research overview
Tesamorelin is a synthetic peptide studied as a stabilized analog of growth-hormone-releasing hormone (GHRH). It acts on the pathway that signals growth-hormone release, and it is one of the more established compounds in the growth-hormone research category.
What is tesamorelin?
Tesamorelin is a modified form of GHRH, engineered to be more stable than the natural hormone. Because it targets the GHRH receptor, research groups it with the growth-hormone secretagogues and analogs, and it is often used as a reference compound in that space.
What research has explored
In research, tesamorelin has been investigated for its action on the growth-hormone axis and downstream metabolic pathways, including studies focused on visceral adipose tissue. These are research findings, not established human outcomes, and tesamorelin is studied as a research material only.
Related compounds
Tesamorelin is studied alongside other growth-hormone research peptides such as CJC-1295, ipamorelin, and sermorelin. Browse the growth-hormone options in the research peptide catalog.
Forms & handling in the lab
Tesamorelin ships as a lyophilized (freeze-dried) powder, commonly in 10 mg research vials. Before use it is reconstituted with bacteriostatic water; the water volume you add sets the concentration in mg/mL.
Storage & stability
- Lyophilized powder - most stable form; keep frozen or refrigerated and protected from light until reconstituted.
- Reconstituted solution - refrigerate at roughly 2-8 °C; as a general research guideline, use within about 28 days.
- Avoid repeated freeze-thaw cycles, heat, and shaking, which can degrade the compound.
Frequently asked questions
What is tesamorelin?
What is tesamorelin studied for?
How is tesamorelin reconstituted?
Related guides
Tesamorelin & GH peptides in the catalog
Live inventory and exact pricing on tesamorelin research vials.
View catalog → Place an order →